Results
GSK Pharma Q2 FY27 Net Profit Rises 33% to INR400 Crore
GSK Pharma reported Q2 FY27 revenue growth of 21% YoY to INR1,180 crore, its highest quarterly sales, with underlying growth of 12-13% excluding tailwinds.
EBITDA grew 20% to INR400 crore with margins
